APPLICATION
ANDA076897
TYPE
ANDA
ORIGINAL APPROVAL
2006-12-01
LATEST ACTION
2007-11-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
OXANDROLONEDiscontinued
OXANDROLONE 2.5MG · TABLET · ORAL
OXANDROLONEDiscontinued
OXANDROLONE 10MG · TABLET · ORAL
Approval history
2007-11-01Labeling · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.